MarketsandMarkets is delighted to announce its Cancer Diagnostics Conference, scheduled to be held on 21st-22nd March 2024 in London. The conference is handcrafted to platform new cancer diagnostics insights, holding discussions on trending technologies along with its latest applications, indicating the challenges in the cancer diagnostics area covering, diagnostic setting, sample processing, regulations, validations, high technology cost, challenges involved in blood – transfusion technology, liquid biopsy, what needs to happen to facilitate better healthcare throughout the world, how therapies work and their side-effects, challenges associated with testing, issues with accuracy & the results.
This event will witness the overwhelming participation of leading healthcare and industry decision-makers who are amplifying the future and are counted as some of the best minds on the planet.
Consultant Gynaecological Oncologist, Gateshead Health NHS Foundation Trust
Cancer Lead – Urology, Princess Alexandra Hospital NHS Trust
Clinical Senior Lecturer, Imperial College London
Colorectal and General Surgeon, NHS
Breast Radiologist, Guy's and St Thomas' NHS Foundation Trust
Surgeon, Buckinghamshire NHS Trust
Reader, Head of Cancer Biomarker and Cellular Endocrinology Lab, Brunel University London